Chronic kidney disease (CKD) is a progressive condition that affects the kidneys’ ability to filter waste and maintain fluid and electrolyte balance. While CKD cannot be completely cured, proper medication management plays a vital role in slowing disease progression, controlling associated symptoms, and improving patient well-being. Below is a list of medications commonly used to support patients living with chronic kidney disorders:
Lenshil 4mg Capsule contains Lenvatinib, a targeted cancer medicine used in the treatment of thyroid cancer, kidney cancer (renal cell carcinoma), and liver cancer (hepatocellular carcinoma).
| Composition | Lenvatinib |
| Manufacturer | Shilpa Medicare Ltd |
| Packing | 10 Capsules in a Strip |
| Prescribed For | Thyroid Cancer, Kidney Cancer, Liver Cancer |
| Expiry | December 2027 |
Lentris 10mg Capsule contains Lenvatinib, a targeted cancer therapy used to treat advanced stages of thyroid cancer, liver cancer (hepatocellular carcinoma), and kidney cancer (renal cell carcinoma).
| Composition | Lenvatinib |
| Manufacturer | Mylan Pharmaceuticals Pvt Ltd |
| Packing | 10 Capsules in a Strip |
| Prescribed For | Thyroid Cancer, Kidney Cancer, Liver Cancer |
| Expiry | December 2027 |
Lenvakast 10mg Capsule contains Lenvatinib, a targeted therapy used in the treatment of advanced thyroid cancer, renal cell carcinoma (kidney cancer), and hepatocellular carcinoma (liver cancer).
| Composition | Lenvatinib |
| Manufacturer | Aprazer Healthcare Pvt Ltd |
| Packing | 30 Capsules in a Strip |
| Prescribed For | Thyroid Cancer, Kidney Cancer, Liver Cancer |
| Expiry | December 2027 |
Lenvat 10mg Capsule contains Lenvatinib, a targeted therapy used in the treatment of thyroid cancer, kidney cancer (renal cell carcinoma), and liver cancer (hepatocellular carcinoma).
| Composition | Lenvatinib |
| Manufacturer | Natco Pharma Ltd |
| Packing | 30 Capsules in a Bottle |
| Prescribed For | Thyroid Cancer, Kidney Cancer, Liver Cancer |
| Expiry | December 2027 |
Lenvatol 10mg Capsule contains Lenvatinib, a targeted anti-cancer medicine used for treating certain types of advanced or metastatic cancers including thyroid cancer, renal cell carcinoma (kidney cancer), and hepatocellular carcinoma (liver cancer).
| Composition | Lenvatinib |
| Manufacturer | Cipla Ltd |
| Packing | 10 Capsules in a Bottle |
| Prescribed For | Thyroid Cancer, Kidney Cancer, Liver Cancer |
| Expiry | December 2027 |
Lenvenib 4mg Capsule contains Lenvatinib, a targeted cancer therapy used to treat advanced thyroid cancer, kidney cancer (renal cell carcinoma), and liver cancer (hepatocellular carcinoma).
| Composition | Lenvatinib |
| Manufacturer | Sun Pharmaceutical Industries Ltd |
| Packing | 7 Capsules in 1 Strip |
| Prescribed For | Thyroid Cancer, Kidney Cancer, Liver Cancer |
| Expiry | December 2027 |
Nitnib 50mg contains Sunitinib Malate, a targeted cancer therapy used to treat certain types of cancers including advanced renal cell carcinoma (kidney cancer), gastrointestinal stromal tumors (GIST), and pancreatic neuroendocrine tumors (pNET).
| Composition | Sunitinib |
| Manufacturer | Zydus Cadila |
| Packing | 7 Capsules in Strip |
| Prescribed For | Kidney Cancer, Gastrointestinal Stromal Tumors & Pancreatic Neuroendocrine Tumors |
| Expiry | December 2027 |
Pazinib 400mg contains Pazopanib, and is used to treat advanced kidney cancer (renal cell carcinoma) and certain types of soft tissue sarcoma in adults who have received prior chemotherapy.
| Composition | Pazopanib |
| Manufacturer | Hetero Healthcare Limited |
| Packing | 30 Tablets in 1 Bottle |
| Prescribed For | Kidney Cancer |
| Expiry | December 2027 |
Sorafekast 200mg contains Sorafenib, a targeted cancer therapy used in the treatment of advanced liver cancer (Hepatocellular Carcinoma), kidney cancer (Renal Cell Carcinoma), and certain types of thyroid cancer.
| Composition | Sorafenib (200mg) |
| Manufacturer | Aprazer Healthcare Pvt Ltd |
| Packing | 120 Tablets in 1 Bottle |
| Prescribed For | Liver Cancer, Kidney Cancer and Thyroid Cancer |
| Expiry | December 2027 |
Sunicine 50mg Capsule contains Sunitinib, a targeted cancer therapy used to treat various cancers, including advanced kidney cancer (Renal Cell Carcinoma), gastrointestinal stromal tumors (GIST), and pancreatic neuroendocrine tumors (pNET).
| Composition | Sunitinib |
| Manufacturer | Arechar Healthcare |
| Packing | 28 Capsules in 1 Bottle |
| Prescribed For | Kidney Cancer and GIST, pNET |
| Expiry | December 2027 |
Sunisam 50 mg Capsules contains Sunitinib, an oral targeted therapy used in the treatment of various cancers, including advanced kidney cancer (Renal Cell Carcinoma), gastrointestinal stromal tumors (GIST), and pancreatic neuroendocrine tumors (pNET).
| Composition | Sunitinib |
| Manufacturer | Samarth Life Sciences Pvt Ltd |
| Packing | 7 Capsules in 1 Strip |
| Prescribed For | Kidney Cancer, GIST and pNET |
| Expiry | December 2027 |
Sunitax 25 mg capsule is a targeted cancer therapy containing Sunitinib Malate, used primarily to treat certain types of advanced cancers such as renal cell carcinoma (kidney cancer) and gastrointestinal stromal tumors (GIST).
| Composition | Sunitinib |
| Manufacturer | Aureate Healthcare Pvt Ltd |
| Packing | 7 Capsules in 1 Strip |
| Prescribed For | Kidney Cancer and Gastrointestinal Stromal Tumors |
| Expiry | December 2027 |
Sunixar 25/50mg Capsule is an oral cancer medication containing Sunitinib Malate, used to treat advanced kidney cancer (renal cell carcinoma), gastrointestinal stromal tumors (GIST), and pancreatic neuroendocrine tumors.
| Composition | Sunitinib |
| Manufacturer | Sun Pharmaceutical Industries Ltd |
| Packing | 7 capsules in 1 Strip |
| Prescribed For | Kidney Cancer, GIST and Pancreatic Neuroendocrine Tumors |
| Expiry | December 2027 |
Sutib 50mg Capsule contains Sunitinib Malate, a targeted cancer treatment used for managing advanced cancers such as renal cell carcinoma (kidney cancer), gastrointestinal stromal tumors (GIST), and pancreatic neuroendocrine tumors.
| Composition | Sunitinib |
| Manufacturer | Glenmark Pharmaceuticals Ltd |
| Packing | 28 Capsules in 1 Box |
| Prescribed For | Kidney Cancer, GIST and Pancreatic Neuroendocrine Tumors |
| Expiry | December 2027 |
Sutinat 50mg Capsule is an oral anti-cancer medication that contains Sunitinib Malate, a targeted therapy used to treat certain advanced cancers such as renal cell carcinoma (kidney cancer), gastrointestinal stromal tumors (GIST), and pancreatic neuroendocrine tumors.
| Composition | Sunitinib |
| Manufacturer | Natco Pharma Ltd |
| Packing | 28 Capsules in 1 Bottle |
| Prescribed For | Kidney Cancer, GIST and Pancreatic Neuroendocrine Tumors |
| Expiry | December 2027 |
Sutykine 50 mg Capsule is an oral targeted therapy that contains Sunitinib Malate, used in the treatment of advanced cancers such as renal cell carcinoma (kidney cancer), gastrointestinal stromal tumors (GIST), and pancreatic neuroendocrine tumors.
| Composition | Sunitinib |
| Manufacturer | Intas Pharmaceuticals Ltd |
| Packing | 7 Capsules in 1 Strip |
| Prescribed For | Anticancer |
| Expiry | December 2027 |
Svitinib 50mg Capsule is an oral anti-cancer medication containing Sunitinib Malate, a targeted therapy used in the treatment of renal cell carcinoma (kidney cancer), gastrointestinal stromal tumors (GIST), and pancreatic neuroendocrine tumors.
| Composition | Sunitinib |
| Packing | 30 Capsules |
| Prescribed For | Kidney Cancer, GIST and Pancreatic Neuroendocrine Tumors |
| Expiry | December 2027 |
Glenvas 10mg Capsule contains Lenvatinib, an oral targeted therapy used to treat certain types of advanced cancers, including thyroid cancer, liver cancer, kidney cancer, and endometrial cancer.
| Composition | Lenvatinib |
| Manufacturer | Glenmark Pharmaceuticals Ltd |
| Packing | 10 Capsules in a Strip |
| Prescribed For | Thyroid, Liver & Kidney Cancer |
| Expiry | December 2027 |
Evermil 5mg tablet contains Everolimus, an anti-cancer medicine used to treat certain types of advanced kidney cancer, breast cancer, neuroendocrine tumors, and tuberous sclerosis-related conditions.
| Composition | Everolimus |
| Manufacturer | Glenmark Pharmaceuticals Ltd |
| Packing | 10 Tablets in 1 Strip |
| Prescribed For | Neuroendocrine Tumors, Kidney & Breast Cancer |
| Expiry | December 2027 |
Cazanat 60mg contains Cabozantinib, a targeted therapy used in the treatment of certain types of cancers, including advanced kidney cancer (renal cell carcinoma) and liver cancer (hepatocellular carcinoma).
| Composition | Cabozantinib |
| Manufacturer | Natco Pharma Ltd |
| Packing | 30 Tablets in 1 Strip |
| Prescribed For | Kidney and Liver Cancer |
| Expiry | December 2027 |
Bevatas 400mg injection contains Bevacizumab, a monoclonal antibody used in the treatment of various types of cancers, including colorectal cancer, lung cancer, kidney cancer, ovarian cancer, and glioblastoma.
| Composition | Bevacizumab |
| Manufacturer | Intas Pharmaceuticals |
| Packing | 16.0 ml in 1 bottle |
| Prescribed For | Anti Cancer |
| Expiry | December 2027 |
Bdfoie 10 mg Capsule contains Lenvatinib, a targeted therapy used in the treatment of certain types of cancers including thyroid cancer, advanced renal cell carcinoma (kidney cancer), and hepatocellular carcinoma (liver cancer).
| Composition | Lenvatinib |
| Manufacturer | BDR Pharmaceuticals |
| Packing | 10 Capsules |
| Prescribed For | Thyroid, Kidney, Lung Cancer |
| Expiry | December 2027 |
